We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.75B
AUM Growth
+$227M
Cap. Flow
+$450M
Cap. Flow %
6.66%
Top 10 Hldgs %
24.03%
Holding
181
New
21
Increased
67
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$76.7M
2
ZYME icon
Zymeworks
ZYME
+$56.8M
3
ENTG icon
Entegris
ENTG
+$55.4M
4
TSM icon
TSMC
TSM
+$52.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$49.2M

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$49.8M
2
W icon
Wayfair
W
+$45.9M
3
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$41.8M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.8M
5
CRWD icon
CrowdStrike
CRWD
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.16%
2 Technology 26.2%
3 Industrials 11.22%
4 Consumer Discretionary 7.43%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POOL icon
26
Pool Corp
POOL
$6.95B
$86.4M 1.28%
250,200
-1,600
-0.6% -$557K
CTAS icon
27
Cintas
CTAS
$82.7B
$83.3M 1.24%
976,800
+260,800
+36% +$22.1M
TRIL
28
DELISTED
Trillium Therapeutics Inc.
TRIL
$82.3M 1.22%
7,659,000
+2,877,552
+60% +$35.6M
TREX icon
29
Trex
TREX
$4.56B
$80.7M 1.2%
882,000
– –
W icon
30
Wayfair
W
$11.9B
$77.6M 1.15%
246,432
-155,568
-39% -$45.9M
VRSK icon
31
Verisk Analytics
VRSK
$26.1B
$75.1M 1.11%
424,800
+5,500
+1% +$1.01M
GNRC icon
32
Generac Holdings
GNRC
$11.3B
$75.1M 1.11%
229,200
+86,200
+60% +$25.4M
MGA icon
33
Magna International
MGA
$19B
$74.7M 1.11%
848,000
+44,700
+6% +$3.63M
APTV icon
34
Aptiv
APTV
$12.3B
$74.1M 1.1%
537,000
– –
EPIX
35
DELISTED
ESSA Pharma
EPIX
$69.9M 1.04%
2,405,169
+70,000
+3% +$1.63M
ENTG icon
36
Entegris
ENTG
$17.8B
$68.9M 1.02%
616,099
+538,470
+694% +$55.4M
RNG icon
37
RingCentral
RNG
$4.48B
$65.9M 0.98%
221,108
+5,210
+2% +$1.92M
VITL icon
38
Vital Farms
VITL
$536M
$65.7M 0.97%
3,008,232
+955,000
+47% +$25.1M
RXDX
39
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$65.6M 0.97%
+3,714,032
New +$76.7M
ARGX icon
40
argenx
ARGX
$54.6B
$58.9M 0.87%
214,000
+54,000
+34% +$17.1M
SPT icon
41
Sprout Social
SPT
$509M
$58.4M 0.87%
1,010,920
-4,000
-0.4% -$251K
COLL icon
42
Collegium Pharmaceutical
COLL
$1.17B
$57.5M 0.85%
2,427,976
– –
ANNX icon
43
Annexon
ANNX
$863M
$54.7M 0.81%
2,004,616
– –
CCI icon
44
Crown Castle
CCI
$33.4B
$54M 0.8%
314,000
+36,600
+13% +$5.86M
STRO icon
45
Sutro Biopharma
STRO
$411M
$54M 0.8%
237,098
– –
TSM icon
46
TSMC
TSM
$2.09T
$53.6M 0.79%
453,100
+427,300
+1,656% +$52.9M
BEP icon
47
Brookfield Renewable
BEP
$9.9B
$52.7M 0.78%
1,236,000
– –
SRPT icon
48
Sarepta Therapeutics
SRPT
$1.64B
$52M 0.77%
697,156
-234,356
-25% -$21.6M
YETI icon
49
Yeti Holdings
YETI
$3.76B
$49.8M 0.74%
690,000
– –
CGEM icon
50
Cullinan Oncology
CGEM
$1.08B
$49M 0.73%
+1,212,555
New +$49.2M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Eventide Asset Management held 181 positions worth $6.75B, up 3.5% from $6.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $450M of net new capital in Q1 2021, opening 21 new positions and adding to 67 existing holdings. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $45.9M trimmed.

  • Eventide Asset Management's largest Q1 2021 buy was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.
  • Eventide Asset Management added most to Entegris in Q1 2021, an estimated $55.4M increase.
  • Eventide Asset Management's biggest Q1 2021 reduction was Wayfair, cutting an estimated $45.9M.
  • Eventide Asset Management fully exited Ecolab in Q1 2021, selling an estimated $49.8M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.75B portfolio in Q1 2021.
  • Eventide Asset Management opened 21 new positions and closed 25 in Q1 2021.
  • Eventide Asset Management's portfolio value rose 3.5% quarter-over-quarter to $6.75B.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.